Stay updated on Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-17T13:54:13.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-10T15:39:12.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A new record version dated 2026-09-28 updates the trial’s eligibility information and study status. The prior version is dated 2026-09-03, replacing the earlier 2026-07-06 date.
    Difference
    0.2%
    Check dated 2026-10-03T15:38:34.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The revision label on the page was updated from Revision: v3.6.6 to Revision: v3.7.0, representing a new version of the page's history component.
    Difference
    0.0%
    Check dated 2026-09-19T19:08:44.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.6.6 replaces v3.6.5 in the page footer, signaling a new build of the site's interface.
    Difference
    0.0%
    Check dated 2026-08-29T21:55:06.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5 instead of v3.6.4, indicating a small site update to the ClinicalTrials.gov interface for the record history page.
    Difference
    0.0%
    Check dated 2026-08-08T23:21:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.